Enhancement of radiation effects by chemotherapy.
D000477:Alkylating Agents / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004273:DNA, Neoplasm; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009062:Mouth Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use; D012334:RNA, Neoplasm; D012175:Retinoblastoma / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D009396:Wilms Tumor / Q000188:drug therapy
D000477:Alkylating Agents; D004273:DNA, Neoplasm; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D012334:RNA, Neoplasm; D003609:Dactinomycin; D008727:Methotrexate